Desensitization Protocol to Atezolizumab and Bevacizumab after Severe Anaphylaxis in the Treatment of Lung Adenocarcinoma.

Desensitization Protocol to Atezolizumab and Bevacizumab after Severe Anaphylaxis in the Treatment of Lung Adenocarcinoma. J Investig Allergol Clin Immunol. 2020 Aug 26;:0 Authors: Gonzalez-Diaz SN, Villarreal-Gonzalez RV, De Lira-Quezada CE, Rocha-Silva GK, Oyervides-Juarez VM, Vidal-Gutierrez O PMID: 32856592 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32856592?dopt=Abstract

Source: Journal of Investigational Allergology and Clinical Immunology - August 25, 2020 Category: Allergy & Immunology Authors: Gonzalez-Diaz SN, Villarreal-Gonzalez RV, De Lira-Quezada CE, Rocha-Silva GK, Oyervides-Juarez VM, Vidal-Gutierrez O Tags: J Investig Allergol Clin Immunol Source Type: research

More News: Adenocarcinoma | Allergy & Immunology | Anaphylactic Shock | Avastin